Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Moodys
AstraZeneca
US Army
Mallinckrodt
Colorcon
Fish and Richardson
Deloitte
Argus Health
Baxter

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,688,530

« Back to Dashboard

Summary for Patent: 5,688,530
Title: Sustained release formulations of water soluble peptides
Abstract:The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
Inventor(s): Bodmer; David (Klingnau, CH), Fong; Jones W. (Parsippany, NJ), Kissel; Thomas (Staufen, DE), Maulding; Hawkins V. (Mendham, NJ), Nagele; Oskar (Sissach, CH), Pearson; Jane E. (Ogendensburg, NJ)
Assignee: Novartis AG (Basel, CH)
Application Number:08/470,909
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 5,688,530

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,688,530

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9016840Aug 01, 1990

International Patents Family Members for US Patent 5,688,530

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 402503 ➤ Try a Free Trial
Austria 406225 ➤ Try a Free Trial
Austria A144090 ➤ Try a Free Trial
Austria A151591 ➤ Try a Free Trial
Australia 2332195 ➤ Try a Free Trial
Australia 4198593 ➤ Try a Free Trial
Australia 4198693 ➤ Try a Free Trial
Australia 5874690 ➤ Try a Free Trial
Australia 641407 ➤ Try a Free Trial
Australia 650277 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Queensland Health
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
US Army
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot